T1	Outcomes 426 532	Dose-limiting toxicity, consisting of febrile reactions in some patients, fatigue, and nonproductive cough
T2	Outcomes 584 646	Dose-related changes in parameters of the acute-phase response
T3	Outcomes 782 838	adverse neurologic consequences of rHCNTF administration
T4	Outcomes 854 874	Antibodies to rHCNTF
T5	Outcomes 1002 1020	safe and tolerated
